Interestingly, none of these 94 patients showed COVID-19 symptoms, which agrees with the reported efficacy of the IL-6 antagonists tocilizumab (Xu et al., 2020) and sarilumab (unpublished observations) in COVID-19 treatment. The gene discussed is IL6; the disease is COVID-19.